THE POTENT AND SELECTIVE B3-ADRENOCEPTOR AGONIST MIRABEGRON IMPROVES PATIENT-REPORTED OUTCOMES IN OVERACTIVE BLADDER-RESULTS FROM TWO PHASE III STUDIES

被引：0
|
作者：
Nitti, V [1 ]
Herschorn, S. [2 ]
Auerbach, S. [3 ]
Khullar, V [4 ]
Amarenco, G. [5 ]
Blauwet, M. B. [6 ]
Boerrigter, P. [7 ]
Hakimi, Z. [8 ]
Siddiqui, E. [9 ]
Martin, N. [10 ]
机构：
[1] NYU Langone Med Ctr, Dept Urol, New York, NY USA
[2] Univ Toronto, Div Urol, Toronto, ON, Canada
[3] Hoag Mem Hosp, Newport Beach, CA USA
[4] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Urogynaecol Dept, London, England
[5] Hop Rothschild, Assistance Publ Hop Paris, Dept Neurol Rehabil, Urodynam & Neurophysiol Lab, F-75571 Paris, France
[6] Astellas Pharma Global Dev Inc, Biostat, Deerfield, IL USA
[7] Astellas Pharma Global Dev EU, Leiderdorp, Netherlands
[8] Astellas Pharma Europe, Leiderdorp, Netherlands
[9] Astellas Pharma Europe Ltd, Staines, Middx, England
[10] Astellas Sci & Med Affairs Inc, Deerfield, IL USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2012年 / 31卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
68
引用
收藏
页码：813 / 815
页数：3
相关论文
共 50 条
  • [41] EFFECT OF VIBEGRON ON QUALITY OF LIFE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL
    Staskin, David R.
    Owens-Grillo, Janet
    Thomas, Elizabeth
    Rovner, Eric S.
    Cline, Kevin
    Mujais, Salim
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1148 - E1149
  • [42] A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
    Herschorn, Sender
    Barkin, Jack
    Castro-Diaz, David
    Frankel, Jeffrey M.
    Espuna-Pons, Montserrat
    Gousse, Angelo E.
    Stoelzel, Matthias
    Martin, Nancy
    Gunther, Adrie
    Van Kerrebroeck, Philip
    UROLOGY, 2013, 82 (02) : 313 - 320
  • [43] Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
    Strand, Vibeke
    Kosinski, Mark
    Chen, Chieh-I
    Joseph, George
    Rendas-Baum, Regina
    Graham, Neil M. H.
    van Hoogstraten, Hubert
    Bayliss, Martha
    Fan, Chunpeng
    Huizinga, Tom
    Genovese, Mark C.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [44] Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
    Vibeke Strand
    Mark Kosinski
    Chieh-I Chen
    George Joseph
    Regina Rendas-Baum
    Neil M. H. Graham
    Hubert van Hoogstraten
    Martha Bayliss
    Chunpeng Fan
    Tom Huizinga
    Mark C. Genovese
    Arthritis Research & Therapy, 18
  • [45] Trospium chloride extended-release formulation provides effective relief for the symptoms of overactive bladder, improves patient-reported quality of life, and is well tolerated: Results from a multicenter, phase III, placebo-controlled study
    Dmochowski, R. R.
    Zinner, N. R.
    Sand, P. K.
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (07) : 1105 - 1106
  • [46] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
    Strand, Vibeke
    Alemao, Evo
    Lehman, Thomas
    Johnsen, Alyssa
    Banerjee, Subhashis
    Ahmad, Harris A.
    Mease, Philip J.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [47] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL
    Navarro-Compan, V.
    Wei, J. C. C.
    Van den Bosch, F.
    Magrey, M.
    Wang, L.
    Fleishaker, D.
    Cappelleri, J. C.
    Wang, C.
    Wu, J.
    Dina, O.
    Fallon, L.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 704 - 704
  • [48] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
    Vibeke Strand
    Evo Alemao
    Thomas Lehman
    Alyssa Johnsen
    Subhashis Banerjee
    Harris A. Ahmad
    Philip J. Mease
    Arthritis Research & Therapy, 20
  • [49] Effects of ruxolitinib cream on patient-reported quality of life in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Armstrong, April W.
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Kallender, Howard
    Gao, Jessy
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E122 - E123
  • [50] Effects of Tofacitinib On Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis Receiving Stable-Dose Methotrexate: Results of Two Phase 3 Studies
    Burmester, Gerd R.
    van der Heijde, Desiree
    Strand, Vibeke
    Zerbini, Cristiano A. F.
    Connell, Carol A.
    Mebus, Charles A.
    Zwillich, Samuel H.
    Bradley, John D.
    Gruben, David
    Wallenstein, Gene
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S549 - S549
12345